TY - JOUR
T1 - Macular vessel density in the superficial plexus is not a proxy of cerebrovascular damage in non-demented individuals
T2 - data from the NORFACE cohort
AU - García-Sánchez, Ainhoa
AU - Sotolongo-Grau, Oscar
AU - Tartari, Juan Pablo
AU - Sanabria, Ángela
AU - Esteban - De Antonio, Ester
AU - Pérez-Cordón, Alba
AU - Alegret, Montserrat
AU - Pytel, Vanesa
AU - Martínez, Joan
AU - Aguilera, Núria
AU - de Rojas, Itziar
AU - Cano, Amanda
AU - García-González, Pablo
AU - Puerta, Raquel
AU - Olivé, Clàudia
AU - Capdevila, Maria
AU - García-Gutiérrez, Fernando
AU - Vivas, Assumpta
AU - Gómez-Chiari, Marta
AU - Giménez, Juan
AU - Tejero, Miguel Ángel
AU - Castilla-Martí, Miguel
AU - Castilla-Martí, Luis
AU - Tárraga, Lluís
AU - Valero, Sergi
AU - Ruiz, Agustín
AU - Boada, Mercè
AU - Marquié, Marta
N1 - Publisher Copyright:
© The Author(s) 2024.
PY - 2024/12
Y1 - 2024/12
N2 - Introduction: Optical coherence tomography angiography (OCT-A) is a novel tool that allows the detection of retinal vascular changes. We investigated the association of macular vessel density (VD) in the superficial plexus assessed by OCT-A with measures of cerebrovascular pathology and atrophy quantified by brain magnetic resonance imaging (MRI) in non-demented individuals. Methods: Clinical, demographical, OCT-A, and brain MRI data from non-demented research participants were included. We analyzed the association of regional macular VD with brain vascular burden using the Fazekas scale assessed in a logistic regression analysis, and the volume of white matter hyperintensities (WMH) assessed in a multiple linear regression analysis. We also explored the associations of macular VD with hippocampal volume, ventricle volume and Alzheimer disease cortical signature (ADCS) thickness assessed in multiple linear regression analyses. All analyses were adjusted for age, sex, syndromic diagnosis and cardiovascular variables. Results: The study cohort comprised 188 participants: 89 with subjective cognitive decline and 99 with mild cognitive impairment. No significant association of regional macular VD with the Fazekas categories (all, p > 0.111) and WMH volume (all, p > 0.051) were detected. VD in the nasal quadrant was associated to hippocampal volume (p = 0.007), but no other associations of macular VD with brain atrophy measures were detected (all, p > 0.05). Discussion: Retinal vascular measures were not a proxy of cerebrovascular damage in non-demented individuals, while VD in the nasal quadrant was associated with hippocampal atrophy independently of the amyloid status.
AB - Introduction: Optical coherence tomography angiography (OCT-A) is a novel tool that allows the detection of retinal vascular changes. We investigated the association of macular vessel density (VD) in the superficial plexus assessed by OCT-A with measures of cerebrovascular pathology and atrophy quantified by brain magnetic resonance imaging (MRI) in non-demented individuals. Methods: Clinical, demographical, OCT-A, and brain MRI data from non-demented research participants were included. We analyzed the association of regional macular VD with brain vascular burden using the Fazekas scale assessed in a logistic regression analysis, and the volume of white matter hyperintensities (WMH) assessed in a multiple linear regression analysis. We also explored the associations of macular VD with hippocampal volume, ventricle volume and Alzheimer disease cortical signature (ADCS) thickness assessed in multiple linear regression analyses. All analyses were adjusted for age, sex, syndromic diagnosis and cardiovascular variables. Results: The study cohort comprised 188 participants: 89 with subjective cognitive decline and 99 with mild cognitive impairment. No significant association of regional macular VD with the Fazekas categories (all, p > 0.111) and WMH volume (all, p > 0.051) were detected. VD in the nasal quadrant was associated to hippocampal volume (p = 0.007), but no other associations of macular VD with brain atrophy measures were detected (all, p > 0.05). Discussion: Retinal vascular measures were not a proxy of cerebrovascular damage in non-demented individuals, while VD in the nasal quadrant was associated with hippocampal atrophy independently of the amyloid status.
KW - BIOFACE
KW - Brain atrophy
KW - Cerebrovascular damage
KW - FACEHBI
KW - NORFACE
KW - Optical coherence tomography-angiography
KW - Vessel density
UR - http://www.scopus.com/inward/record.url?scp=85185452350&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85185452350&partnerID=8YFLogxK
U2 - 10.1186/s13195-024-01408-9
DO - 10.1186/s13195-024-01408-9
M3 - Article
C2 - 38378643
AN - SCOPUS:85185452350
SN - 1758-9193
VL - 16
JO - Alzheimer's Research and Therapy
JF - Alzheimer's Research and Therapy
IS - 1
M1 - 42
ER -